Clinical trial
Management of Women With BRCA1/2 Mutation
NCT03211611
Study timeline
Study start (actual)2017-04-01Date precision: day
Registry last updated2018-05-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
BRCA1 Mutationunresolved
BRCA2 Mutationunresolved
Interventions
Questionnaire given to the two groupsBEHAVIORAL
Sponsors & collaborators
University Hospital, Montpellierlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03211611 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.